+987.9%
MRNA vs UAL
+22.8%
+965.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UAL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +8.0% | +5.1% | +11.3% |
| 7D | +20.6% | +11.9% | +8.7% | +17.9% |
| 30D | +27.1% | +5.2% | +21.9% | +25.4% |
| 3M | +353.4% | -12.7% | +366.1% | +367.1% |
| 6M | +446.3% | +28.5% | +417.7% | +401.8% |
| YTD | +776.2% | +3.5% | +772.6% | +727.4% |
| 1Y | +987.9% | +27.5% | +960.4% | +846.0% |
| All | +987.9% | +22.8% | +965.1% | +846.0% |
Cumulative growth
Daily Returns
Daily percentage return beside UAL.
Daily Out/Under-Performance
Portfolio return minus UAL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UAL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UAL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling